FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2340213079> ?p ?o ?g. }

• W2340213079 endingPage "29707" @default.
• W2340213079 startingPage "29689" @default.
• W2340213079 abstract "// Rajeev K. Boregowda 1 , Daniel J. Medina 1 , Elke Markert 2 , Michael A. Bryan 1 , Wenjin Chen 3, 4 , Suzie Chen 5 , Anna Rabkin 5 , Michael J. Vido 6 , Samuel I. Gunderson 7 , Marina Chekmareva 4 , David J. Foran 3, 4 , Ahmed Lasfar 8, 9 , James S. Goydos 10 , Karine A. Cohen-Solal 11 1 Division of Medical Oncology, Department of Medicine, Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08903, USA 2 Cancer Research UK Beatson Institute, Glasgow, G61 1BD Scotland, UK 3 Center for Biomedical Imaging & Informatics, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA 4 Department of Pathology and Laboratory Medicine, Robert Wood Johnson University Hospital, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA 5 Department of Chemical Biology, Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, New Brunswick, NJ 08903, USA 6 Department of Cancer Biology and Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA 7 Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, NJ 08854, USA 8 Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA 9 Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA 10 Division of Surgical Oncology, Department of Surgery, Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey, Rutgers, the State University of New Jersey, New Brunswick, NJ 08901, USA 11 Section of Surgical Oncology Research, Department of Surgery, Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA Correspondence to: Karine A. Cohen-Solal, email: cohenska@cinj.rutgers.edu Keywords: melanoma, transcription factor, RUNX2, receptor tyrosine kinase, resistance to targeted therapy Received: November 16, 2015     Accepted: March 28, 2016     Published: April 18, 2016 ABSTRACT Receptor tyrosine kinases-based autocrine loops largely contribute to activate the MAPK and PI3K/AKT pathways in melanoma. However, the molecular mechanisms involved in generating these autocrine loops are still largely unknown. In the present study, we examine the role of the transcription factor RUNX2 in the regulation of receptor tyrosine kinase (RTK) expression in melanoma. We have demonstrated that RUNX2-deficient melanoma cells display a significant decrease in three receptor tyrosine kinases, EGFR, IGF-1R and PDGFRβ. In addition, we found co-expression of RUNX2 and another RTK, AXL, in both melanoma cells and melanoma patient samples. We observed a decrease in phosphoAKT2 (S474) and phosphoAKT (T308) levels when RUNX2 knock down resulted in significant RTK down regulation. Finally, we showed a dramatic up regulation of RUNX2 expression with concomitant up-regulation of EGFR, IGF-1R and AXL in melanoma cells resistant to the BRAF V600E inhibitor PLX4720. Taken together, our results strongly suggest that RUNX2 might be a key player in RTK-based autocrine loops and a mediator of resistance to BRAF V600E inhibitors involving RTK up regulation in melanoma." @default.
• W2340213079 created "2016-06-24" @default.
• W2340213079 creator A5021405510 @default.
• W2340213079 creator A5025954072 @default.
• W2340213079 creator A5029537735 @default.
• W2340213079 creator A5033500872 @default.
• W2340213079 creator A5040466212 @default.
• W2340213079 creator A5062982351 @default.
• W2340213079 creator A5066228012 @default.
• W2340213079 creator A5071451951 @default.
• W2340213079 creator A5073946905 @default.
• W2340213079 creator A5074258023 @default.
• W2340213079 creator A5079683086 @default.
• W2340213079 creator A5082277994 @default.
• W2340213079 creator A5089373018 @default.
• W2340213079 creator A5091466510 @default.
• W2340213079 date "2016-04-18" @default.
• W2340213079 modified "2023-10-16" @default.
• W2340213079 title "The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma" @default.
• W2340213079 cites W1480838859 @default.
• W2340213079 cites W1607548879 @default.
• W2340213079 cites W1651215666 @default.
• W2340213079 cites W1919536350 @default.
• W2340213079 cites W1965880322 @default.
• W2340213079 cites W1969717303 @default.
• W2340213079 cites W1976550852 @default.
• W2340213079 cites W1985928174 @default.
• W2340213079 cites W1993497504 @default.
• W2340213079 cites W1998863388 @default.
• W2340213079 cites W2002157424 @default.
• W2340213079 cites W2004706898 @default.
• W2340213079 cites W2005530000 @default.
• W2340213079 cites W2011261819 @default.
• W2340213079 cites W2018712322 @default.
• W2340213079 cites W2027473831 @default.
• W2340213079 cites W2028415754 @default.
• W2340213079 cites W2028968731 @default.
• W2340213079 cites W2030150987 @default.
• W2340213079 cites W2032211985 @default.
• W2340213079 cites W2037495678 @default.
• W2340213079 cites W2038264590 @default.
• W2340213079 cites W2041768004 @default.
• W2340213079 cites W2044895919 @default.
• W2340213079 cites W2048408428 @default.
• W2340213079 cites W2050573392 @default.
• W2340213079 cites W2052005627 @default.
• W2340213079 cites W2052622098 @default.
• W2340213079 cites W2052935729 @default.
• W2340213079 cites W2060938351 @default.
• W2340213079 cites W2063112516 @default.
• W2340213079 cites W2070035704 @default.
• W2340213079 cites W2070277316 @default.
• W2340213079 cites W2070819820 @default.
• W2340213079 cites W2083603419 @default.
• W2340213079 cites W2083870593 @default.
• W2340213079 cites W2084232727 @default.
• W2340213079 cites W2087835012 @default.
• W2340213079 cites W2090120410 @default.
• W2340213079 cites W2090176789 @default.
• W2340213079 cites W2092194090 @default.
• W2340213079 cites W2096459042 @default.
• W2340213079 cites W2096575630 @default.
• W2340213079 cites W2100614336 @default.
• W2340213079 cites W2102927263 @default.
• W2340213079 cites W2104029317 @default.
• W2340213079 cites W2104816793 @default.
• W2340213079 cites W2106193886 @default.
• W2340213079 cites W2107277218 @default.
• W2340213079 cites W2107385057 @default.
• W2340213079 cites W2114843025 @default.
• W2340213079 cites W2115382934 @default.
• W2340213079 cites W2116978375 @default.
• W2340213079 cites W2118322364 @default.
• W2340213079 cites W2130434604 @default.
• W2340213079 cites W2131110612 @default.
• W2340213079 cites W2131998303 @default.
• W2340213079 cites W2138735856 @default.
• W2340213079 cites W2139182006 @default.
• W2340213079 cites W2141674733 @default.
• W2340213079 cites W2143191174 @default.
• W2340213079 cites W2147690515 @default.
• W2340213079 cites W2147694985 @default.
• W2340213079 cites W2149193631 @default.
• W2340213079 cites W2149441684 @default.
• W2340213079 cites W2149730494 @default.
• W2340213079 cites W2159750196 @default.
• W2340213079 cites W2167341806 @default.
• W2340213079 cites W2192080449 @default.
• W2340213079 cites W2244368680 @default.
• W2340213079 cites W273611013 @default.
• W2340213079 cites W48986072 @default.
• W2340213079 doi "https://doi.org/10.18632/oncotarget.8822" @default.
• W2340213079 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5045426" @default.
• W2340213079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27102439" @default.
• W2340213079 hasPublicationYear "2016" @default.
• W2340213079 type Work @default.
• W2340213079 sameAs 2340213079 @default.
• W2340213079 citedByCount "22" @default.

• next